Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Stephen Shulman, M.D.

Title
Institution
Department
Address

Biography
Harvard Medical School, Boston, MAMD06/2013Medicine
Boston Combined Residency in Pediatrics, Boston, MA06/2014Internship
Boston Combined Residency in Pediatrics, Boston, MA06/2016Residency
Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA06/2019Fellowship (Pediatric Hematology/Oncology)

Mentoring
Available: 01/02/24, Expires: 12/02/24

Sarcomas are rare and often aggressive cancers that arise from connective tissues. In recent decades, progress in improving outcomes for sarcomas affecting adolescents and young adults has been minimal. Patients undergo aggressive surgeries, radiation and often intensive chemotherapy. Today, most sarcoma subtypes of no validated biomarkers to inform novel approaches to therapy. Dr. Shulman's research program is dedicated investigating and validating liquid biopsy technologies as clinical biomarkers in AYA Sarcomas. These biomarkers will inform novel approaches to therapy aimed at improving cure rates and decreasing late effects. We have multiple potential projects for an interested medical student that could be in person or remote. These include analyzing clinical genomics of liquid biopsy testing for specific AYA sarcoma subtypes, medical record review to identify associations between liquid biopsy results and clinical outcomes, and manuscript writing. Please reach out if interested.


Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. 5KL2TR002542-03 (David Shulman) Oct 1, 2020 - Sep 30, 2022
    Harvard Catalyst / NIH. - KL2/CMeRIT
    Evaluation of precision biomarkers and targeted therapies in patients with Ewing sarcoma
    Role: Trainee

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Updating...
This operation might take several minutes to complete. Please do not close your browser.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Shulman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (157)
Explore
_
Co-Authors (53)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.